CORPORATE

Plasma in the fight against COVID-19 Alongside the Italian National Health Service and hospitals for plasma therapy Industrial viral inactivation as an additional option Hyperimmune Immunoglobulins Contract Manufacturing in Italy Plasma in the fight against COVID-19 To cope with the serious health emergency caused by the SARS-Cov-2 pandemic, companies that produce plasma derivatives worldwide are

Kamada is Responsible for Product Development, Manufacturing, Clinical Development, and Regulatory Submissions, as well as Distribution in Territories not under Kedrion’s Responsibility Kedrion is Responsible for the Collection and Supply of Plasma from Convalescent COVID-19 Patients, Support of Clinical Development and Distribution in the U.S., Europe, Australia, and S. Korea   Rehovot, Israel and Castelvecchio

Kedrion’s commitment to find a treatment from convalescent patient plasma

The project will be developed by the EngageMinds Hub Research Center of the Catholic University of the Sacred Heart

An initiative which is a testimony to the close relationship between our two Countries in times of difficulty

The home delivery program offered by Domedica is called #KoalaACasaTua

In accordance with international, national and local authority guidelines, Kedrion has acted immediately in dealing with the epidemiological emergency linked to the spread of the novel Coronavirus, and has taken all necessary measures to safeguard the health and safety of its employees and guarantee continuation of business activities. Paolo Marcucci, Chairman & CEO has stated:

Communication from Paolo Marcucci, Chairman & CEO of Kedrion

An important step in consolidating the role of the Campania site within Kedrion’s production system

Two scholarships awarded to young researchers in the field of non-oncological hematology